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Abstract
New psychoactive substances (NPS) remain a global public health and clinical challenge. Popular
NPS include synthetic cannabinoids (SCs). A conceptual metaphorical analysis of user experiences
of SCs was conducted in two European countries (Western and Central European). Metaphors are
increasingly used to better understand drug user experiences and as medium to inform and guide
clinical responses. Semi-structured interviews with 12 SC users were conducted in Hungary (n= 6)
and Ireland (n = 6). Thematically segmented texts of SC usage (1) motivation, (2) effects, (3)
consequences and (4) the setting were selected. A systematic analysis of conceptual metaphors was
conducted on the selected texts. The conceptual target and source domains of the experiences of SC
usage (motivation, effects, consequences) were analysed. Four conceptual source domains were
found in all of the segmented and analysed narratives of psychological factors (motivations, effects,
consequences): change in the vertical perception, perceiving that SC is everywhere, feeling
disconnected, recognition of lack of control and identifying the SC as a destroying entity. The
conceptual metaphors reflect how users perceive experiences of SC use, the discrepancy between
the experience of embodiment and disembodiment. This study provides clinicians with an insight
into the experiences of SC motivations, effects and consequences and can be used to inform and
guide clinical and therapeutic responses in the support of those recovering from SC dependence.
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New psychoactive substances (NPS) remain a global public health and clinical challenge
(Gunderson et al. 2012; Spaderna et al. 2013; Corazza et al. 2013; EMCDDA 2015; Van Hout
and Hearne 2017; Kassai et al. 2017a; Dolengevich-Segal et al. 2017; Barnard et al. 2017). The
United Nations Office on Drugs and Crime (UNODC) defines NPS as ‘substances of abuse,
either in a pure form or a preparation, that are not controlled by the 1961 Single Convention on
Narcotic Drugs or the 1971 Convention on Psychotropic Substances, but which may pose a
public health threat’ (UNODC 2013). This broad NPS concept encompasses not only new
compounds but also emerging trends in available substances, new contexts and routes of use
and diffusion (Dolengevich-Segal et al. 2017). The number and range of NPS continue to
increase globally. The World Health Organisation (WHO) indicated a rise of 55% in newly
identified NPS in 2015, with the Early Warning System (EU-EWS) in Europe detecting 100
newly identified NPS in 2015. By 2016, over 560 NPS were under surveillance by the
European Monitoring Centre for Drugs and Drug Addiction (UNODC 2013; Dolengevich-
Segal et al. 2017; Barnard et al. 2017; EMCDDA 2015).
Synthetic Cannabinoids (SC)
NPS are marketed as illicit drug replacements, but carry user risk and harm due to the lack of
information on toxicology and content (EMCDDA 2015). One such NPS are the synthetic
cannabinoids (SCs) known as Spice, K2, Kronic (Bright et al. 2013; Baumann et al. 2014;
Fantegrossi et al. 2014; Zawilska and Wojcieszak 2014), intended to replace natural cannabis
and generally sold as herbal smoking mixtures. SCs emerged in Europe as early as 2004
(Griffiths et al. 2010; Schifano et al. 2009). Most prevalent synthetic cannabinoids compounds
are CP 47,497-C8, JWH-081, JWH-250, JWH-018 and JWH-073 (Gunderson et al. 2012;
Zawilska and Wojcieszak 2014). New-generation SCs include the hexyl homolog JWH-019
(Dresen et al. 2011), the aminoalkylindoles JWH-073 (Lindigkeit et al. 2009), JWH-250
(Westphal et al. 2010) and JWH-398 (Hudson et al. 2010) and JWH-015, JWH-122, HU-
210 and AM-694 (EMCDDA 2009; Ernst et al. 2011). More recently, 5f-AKB48 and 5F-PB-
22 have been detected in both seizures and fatalities (Roussel et al. 2015; Van Hout and Hearne
2017). These synthetic psychoactive compounds are sprayed or added to the herbal mixtures
(Uchiyama et al. 2010) generally sold in metal foil sachets containing 1–3 g of dried leaves,
resin or flowers (Dresen et al. 2011; Zuba et al. 2011; Kikura-Hanajiri et al. 2011; Zawilska
and Wojcieszak 2014). Labelling on these herbal products often denotes ‘not for human
consumption’ or ‘for aromatherapy only’ (Zawilska and Wojcieszak 2014). SCs in contrast
to natural cannabis or phytocannabinoids (delta-9-tetrahydrocannabinol or THC) which are
partial agonists are potent high efficacy cannabinoid receptor full agonists (Lindigkeit et al.
2009; Vardakou et al. 2010; Tuv et al. 2012). Prevalence data reports on use of SCs in
adolescents and young adults (primarily male) estimated to be around 10% (Hu et al. 2011;
Forrester et al. 2011; Vandrey et al. 2012), with global data suggesting lifetime use is higher
(16.8%) (Winstock and Barratt 2013).
Motivation to Use and Effects of SC
Motivations to experiment and use SCs centre on their availability, low pricing and inability to
be detected in standard drug testing (Castellanos et al. 2011; Meshack et al. 2013; Arfken et al.
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2014; Van Hout 2017). SC users report on euphoric pleasurable effects both similar to natural
cannabis and distinct to SCs (drowsiness, time distortion, inability to think clearly, hallucina-
tions) and general use for intoxication and relaxation purposes (Schneir et al. 2011; Fattore and
Fratta 2011; Vandrey et al. 2012; Barratt et al. 2013; Soussan and Kjellgren 2014; Bonar et al.
2014; Van Hout and Hearne 2017; Kassai et al. 2017a). Decisions to use herbal mixtures are
also grounded in a perception of safety (Fattore and Fratta 2011; Vandrey et al. 2012; Van Hout
and Hearne 2017).
In comparison to natural cannabis, available literature indicates that more unpredictable and
adverse symptomatology is reported by users (Bonar et al. 2014; Castaneto et al. 2014;
Fantegrossi et al. 2014; Van Hout and Hearne 2017; Kassai et al. 2017a). Users describe
intense and rapid trajectories of SC use from positive toward the negative and with dependent
resulting in severe psychopathological and withdrawal symptoms (Zimmermann et al. 2009;
Van Der Veer and Friday 2011; Nacca et al. 2013; Macfarlane and Christie 2015; Bilgrei 2016)
and solitary daily use (Van Hout and Hearne 2017; Kassai et al. 2017a). Continued and
compulsive use characterized by craving and multiple re-dosing, despite fear around psychotic
and other unpleasant effects (panic, paranoia, aggression, chest pain, palpitations, anxiety,
insomnia) is common (Vandrey et al. 2012; Winstock and Barratt 2013; Barratt et al. 2013;
Fattore 2016; Van Hout and Hearne 2017; Kassai et al. 2017a).
Emergency hospital presentations are characterised by patients presenting with panic
attacks, agitation, paranoid ideation, tachycardia, nausea, psychotic reactions and hallucina-
tions post SC use (Sobolevsky et al. 2010; Vearrier and Osterhoudt 2010; Forrester et al. 2011;
Castellanos et al. 2011; Every-Palmer 2010, 2011; Schneir et al. 2011; Bebarta et al. 2012;
Spaderna et al. 2013). Winstock et al. (2015), in their study on patients seeking emergency
medical treatment following SC use, with the relative risk of severity of side effects estimated
to 30 times greater than natural cannabis. Clinical treatment of acute intoxication generally
remains symptomatic and short (intravenous saline and benzodiazepines) and targeted to deal
with agitation, tachycardia and nausea lasting up to 24 h (Castaneto et al. 2014; Fattore 2016).
Adverse medical events caused by SC use include hyperemesis, kidney failure, seizures,
cardiovascular events and psychiatric presentations (Tait et al. 2016). Anxiety and psychotic
symptoms following acute intoxication reportedly last several days to weeks (Every-Palmer
2011; Bassir Nia et al. 2016), and in some studies, deteriorate and persist subsequent to the SC
episode (Müller et al. 2010; Hurst et al. 2011; Van Der Veer and Friday 2011; Tung et al. 2012;
Van Hout and Hearne 2017). Kassai et al. (2017b), in their identity work on SC users, illustrate
how SC experiences are similar to traumatic experiences, representing additional difficulties in
recovery. Reviews indicate that SCs can exacerbate psychotic symptoms in previously stable
individuals or trigger new onset psychosis in those with no previous history of psychosis
(Fattore 2016). In terms of treating dependence, patients with SC withdrawal symptoms often
require intense medical support and admission to inpatient detoxification (Macfarlane and
Christie 2015; Van Hout and Hearne 2017; Van Hout 2017).
Metaphors in Qualitative Drug Research
Metaphors are increasingly used to better understand drug user experiences and as medium to
inform and guide clinical responses. Participants describe their drug-related experiences and a
myriad of metaphors are recognizable in their depictions. Lakoff and Johnson (2008), in their
conceptual metaphor theory, give a description of the metaphor as a common everyday
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linguistic practice that is not only present in the literary language as a rhetorical instrument.
Moreover, metaphorical expressions are part of the language we live by, which are detectable
in the pronouns and the linguistic structures we are unconsciously using. This is especially
applicable to drug users and drug-related language and nomenclature.
Johnson and Lakoff (2002) suggest that conceptual metaphors are rooted in bodily under-
standing of the world surrounding us and that embodied concepts are rooted in the experiences
of the individual. Experiences can be explored by understanding the metaphorical mapping of
the structure, the conceptual target and the source domains of metaphorical expressions the
individual is using in describing specific experiences (Gibbs 2006; Kövecses 2003, 2010;
Lakoff and Johnson 1980).
The conceptual metaphor theory provides a basis for systematic metaphor analysis as a
method of qualitative research in social science (Schmitt 2005). Conceptual metaphors are
analysed in the different fields of social science and the importance of metaphors in drug use
have been long recognized in drug policy issues (Moore et al. 2015; Perlman and Jordan
2017), in drug treatment (Gryczynski et al. 2007), in progression and recovery of alcoholism
(Jellinek 1946) and in revealing the experience of addiction (Shinebourne and Smith 2010;
Gerçek 2017).
Metaphors of everyday alcohol consumption and their implications for counselling and
prevention are inevitable (Schmitt 2005). Authors Rácz and Kaló (2009), in a preliminary
study, have recognized the different conceptual metaphors of substance use by comparing
Hungarian narratives of the personal experiences of the effects of heroin, amphetamine and
marijuana.
Kaló and colleagues Kaló et al. (2013) also designed a study to compare the conceptual
metaphors of the first known NPS, (4-MMC, mephedrone) from interviews conducted with
Hungarian and Irish users. The study found that mephedrone had a complex effect on users
which was expressed with metaphors from similar source domains in both languages. Differ-
ences were found if the setting of the mephedrone taking was different (injecting, snorting)
(Kaló et al. 2013).
Rationale
Two qualitative studies with SC users were undertaken by authors in two European countries,
namely Hungary (Kassai et al. 2017a, b) and the Republic of Ireland (Van Hout and Hearne
2017). NPS appeared in Hungary in 2010, with significant increases in popularity reported in
2014 (Rácz et al. 2016; Reitox National Focal Point 2016). User peer networks and online
availability supported sourcing, despite generic regulation in Hungary (Reitox National Focal
Point 2016). Similar patterns occurred in Ireland (Van Hout and Brennan 2011a, b, c; 2012;
Van Hout and Bingham 2012; Van Hout 2017), and where SCs emerged as a significant
community and clinical concern since 2015 (Van Hout and Hearne 2017; Van Hout 2017).
Metaphors are increasingly used to better understand drug user experiences and as medium
to inform and guide clinical responses. The main concern of this paper is about understanding
the meaning of SC usage in terms of latent and implicit contents of users’ narratives; how the
users of SC make sense of the world and how they experience SC usage across the trajectory of
use, abuse and dependence. The theoretical background is defined by the conceptual metaphor
analysis (Lakoff and Johnson 1980). Metaphors are culturally and socially defined, and yet
they also represent a basic cognitive strategy of analogical problem solving. Metaphors are
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context-sensitive, yet at the same time, they are abstract models of reality much in the same
way as mental models and schemata in cognitive psychology (Moser 2000). We are applying
metaphor analysis to these SC narratives, to provide insight into the analogical problem
solving as it relates to the use of SCs as described by the lived experiences of users in
Hungary and Ireland. This type of work contributes to the literature on NPS and indeed illicit
drug use by virtue of its new approach, which goes beyond the simple descriptor level and
attempts to yield insight into problem solving as experienced by users of this addictive and
destructive synthetic drug.
Hence, the focus of our study of SC metaphors based on user experiences was to gain a
richer insight into the experience of SC usage by identifying and systematically comparing the
language use and their conceptual metaphorical background related to SC use in English and
Hungarian reports. By the comparison of different languages, we aimed to identify more
information about the universal internal mental images and perspectives of SC use. The
research questions were as follows;
& What kind of conceptual metaphors are used by the SC users in describing their experi-
ences with SC?
& What are the differences and commonalities between the Irish and the Hungarian reports
regarding the metaphors of SC usage?
& What are the common conceptual source domains found in the metaphors of SC use?
Methods
We applied the conceptual metaphor theory as a method to understand universality of SC
motivations, effects and consequences across to distinct cultural contexts, Hungary and
Ireland. We used semi-structured interviews for data collection. We conducted interviews
separately in the two countries, which were then transcribed verbatim. The data analysis was
conducted by two independent researchers of the study.
Sample
In the Republic of Ireland, six dependent users (three males/three females) of herbal smoking
mixtures known to contain the SC’s 5f-AKB48 and 5F-PB-22 were interviewed. The study
was undertaken in 2015 at a time where Ireland was experiencing significant community and
clinical concerns for cross border tourism for NPS, increased crisis presentations at emergency
health services and SC-related suicides. This sample had an average Severity of Dependence
Score (SDS) of 13. The methodology is reported elsewhere (Van Hout and Hearne 2017). This
sample differed from the Hungarian sample by virtue that none had attended treatment services
and all reported attempts to self-detoxify at home.
In Hungary, six male self-identified SC users were recruited, who had problematic SC use
and entered treatment. No female users were available. It was assumed that SCs were the
dominant components of the substance that they smoked, the exact compounds of these
substances are unknown. Before the analysis, they had been using SC for at least 2–6 years,
and at the time of the study, they had been abstinent for at least 1 month. The methodology is
reported elsewhere (Kassai et al. 2017a, b).
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Ethics
The Irish study was conducted in accordance with the ethical standards laid down in the 1964
Declaration of Helsinki, and the institutional ethical policies for conducting research. All
participants received an information sheet and gave written informed consent prior to the
interview. All were assured of confidentiality and anonymity and that they could withdraw
from the study if requested. Audio recordings were destroyed post-transcription (Van Hout and
Hearne 2017). The study protocols of Hungarian study were approved by the Institutional
Review Board at Eötvös Loránd University. The participation in the study was voluntary;
anonymity and confidentiality were assured to protect participants’ identity. All the partici-
pants approved the condition of participation (Kassai et al. 2017a, b).
Analysis
In the analysis, we used the conceptual metaphor theory (Lakoff and Johnson 1980; Schmitt
2005) to identify the metaphors of SC usage. First, we identified the conceptual target area for
metaphor analysis: in this study, the target area was SC use; we aimed to understand the
metaphorical concepts related to SC use, how users describe it naturally and linguistically. In
the conceptual metaphorical analysis, we focused on the narratives of personal experiences and
pathways of SC use. Metaphors, their target and source domains associated with the effects
and usage of SC were defined and systematic correspondences (mappings) between the
Hungarian and Irish metaphorical expressions were stated. Metaphoric implications of map-
pings and different aspects of notions used in metaphors were examined and compared with
conceptual metaphors used in the English and the Hungarian language. The entire interviews
were close read and reports of personal experience with SC were selected and analysed.
Procedure
First, we selected extracts of the interview texts where the user described any aspect of
SC usage. These reduced interview text sequences were analysed for the conceptual
metaphors of SC usage. The data was analysed in the original language; later, the
Hungarian analysis results were translated to English. The interview text segmentation
was theory-driven, based on the synthesis of the addiction motivation theory (PRIME
model Michie et al. 2011). Drug usage and addiction are viewed to consist of a number
of distinct common components such as: the effects, the motivations and the conse-
quences (Kaló et al. 2013).
Second, we analysed the conceptual metaphors of the segmented texts in both lan-
guages. We looked for the conceptual source domains of the effects, motivations and
consequences in the narratives of Irish and Hungarian SC users. Results are shown in the
above detailed system of motivations and the segmented components of SC experience.
Third, we made a synthesis of the common conceptual source domains regarding SC usage.
Segmentation of the Interview Texts
The experiences with SC were segmented into the following components: the effects, the
motivations, the consequences and the setting. The effects included those narratives that
described the result of using SC, and any of those phenomena (behaviours, feelings, etc.)
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that were produced by SC. The motivation narratives included those sequences that
described the user’s reasons (motives) for taking SC; the inspiration that was arisen the
person to take action; the purpose and direction to behave. The consequences as sub-
theme consisted of the unwanted effects, and the after-effects, in terms of the phenomena
observed after the desired effect. The setting as a general social factor was also added as
a category in the analysis. It refers to the Irish or Hungarian setting.
Results
Summary of Results: Conceptual Source Domain of SC Metaphors
The embodied experience of SC usage was described by the SC users in the English and
Hungarian narratives by specific conceptual source domain. Four conceptual source
domains were found in all of the segmented and analysed narratives of psychological
factors (motivations, effects, consequences): the change in the vertical perception, the
feeling of perceiving that SC is everywhere, the feeling of disconnectedness, the recog-
nition of lack of control and the identification of SC as a destroying entity (Table 1).
SC Enhances Changes in the Spatial Perceptions
The SC enhanced a change in the spatial perceptions that was reflected in the conceptual
source domains. The first experience with SC was usually positive: if the user was up,
the SC brought them down; if the user was down, the SC brought them up. The state
was reached with the help of SC, whether it is up or down, it was regarded a positive
change. The Hungarian metaphor reflected an autonomous power; the SC had the power
to change the user’s perception that was regarded on a vertical scale. In both languages,
the power of the SC was also reflected in the spatial changes perceived horizontally. The
SC had made the user feel emptied and indifferent; the SC locked the outside world
forcing the user focus and zoom inside.
Table 1 SC metaphors and correspondences
Metaphors Correspondences
Elements of source domain Elements of target
domain
SC is a magnetic
field
A magnetic field changes the powers when something gets closer It changes the spatial
perceptions
The magnetic field once it is there, it cannot be moved SC is everywhere
The magnetic field/the destructive entity does something against
the will of the person
Losing control
Loss of control
Disconnects from the
world
SC is a destructive
entity
The entity has autonomy Destruction of the body
The entity has a will Death
The entity has a destructive will
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SC Is Identified as a Destroying Entity
This metaphor reflected that SC had held the autonomous power over the user. The conceptual
metaphors of SC as a destroying entity reflected that the user had become more and more
powerless and the SC was perceived as something that held the power and became progres-
sively autonomous. It took the control over the user’s life; moreover, it tricked with the mind,
the forces, and the moves. The Hungarian users identified the SC as a destroying agent thus,
themselves as entities losing control that were not capable of doing anything, and were not able
to guide or control. In the Irish data, the control by the SC was so extreme, that they had
described the SC as an entity that is gradually and deliberately killing them.
Metaphors of Motivations
The conceptual metaphors implicated that the users lack the agency or the responsibility
in the motivations. Users described their experience on getting in touch with the SC
where they were feeling that their approval was not needed. As if the substance would
have been actively present everywhere and they had not been able to control the
interaction between them and the substance.
SC is something that acted like a magnet. It was not everywhere but had a magnetic force
that had pulled the users wherever they were.
It’s a magnet altogether coz no matter where you go, its there. /Irish data/
‘SC is everything and everywhere’ was general in describing the SC experience. In this
metaphor, the conceptual target domain was the motivations for SC use, and the conceptual
target domain in both languages (English and Hungarian) was described with the ‘every’
determiner (Table 2).
Metaphors of Effects
The metaphors of effects of SC experience as conceptual target domains were described
with a conceptual source domain of different prepositions (e.g. up, down, in, out)
describing the directions of the movement. SC was something that changes in the
movement perception vertically (high, up) in both the Irish and the Hungarian narratives
(Table 3):
I feel happy, I feel relaxed, I feel calm, I feel the world is on my side. But if I haven’t got
it I feel the world is against me. I sweat, I can’t eat, I can’t think straight. Yet when I get
that smoke everything changes. I’m up real high but if I haven’t got it I’m down as low
as you can get.
Table 2 Motivation: SC is everywhere
Irish data Hungarian data
Herbal is a curse. It’s a curse on everybody in this town, to be honest
It works every way—money wise, condition wise, health wise, everything
no matter where you go it’s there
It’s everywhere
It is everywhere, it solved itself to
be everywhere
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The metaphors of effects of SC experience as conceptual target domains included expres-
sions that were implicating losing control over their body and mind. The body and mind acted
differently. The user lost their agency; their body was craving for the substance (Table 4).
Like, see the way you can feel like yourself now, I can’t get that anymore, it’s all herbal
to me now. It’s terrible, it’s taken over my life and I don’t want to do it, man. If I haven’t
got it I go mad, break the house up, put my hands through doors, walls, windows. I
broke a window there last week. It’s just ridiculous, I go mad, I cant even control myself,
I go mad like ... /Irish data/
From the first moment, it was governing me, I couldn’t handle it, I was just sitting for
hours. /Hungarian data/
Thirdly, the metaphors of effects of SC experience as conceptual target domains were
described by the Hungarian users inclusively with the conceptual source domains of discon-
nection. The SC disconnected the user from the world, their body, their ‘brain’ (Table 5).
Metaphors of Consequences
The metaphorical source domains of the consequences of SC were different prepositions (e.g.
down) describing the direction of the movement. These movements were opposite to the ones
describing the effects (up and down). The metaphors of consequences were formulated by
linguistic expressions from the conceptual source domain describing it as something that had
changed in the movement perception vertically in both the Irish and the Hungarian narratives
(Table 6):
At the beginning it was very good, I felt good from it/SC, I was up, I was happy, like
that, like these things that were inside me, I felt better like I started listening to the music
Table 3 Motivation: SC disconnects from the world
Hungarian data
The world is disconnected, and it is just me, I am zoomed
The world is narrowing down
I feel a little disconnected
It turns my brain off
My brain goes stiff
I was feeling scattered
Table 4 Effects of SC use: brings up
Irish data Hungarian data
I could not come up and talk to anybody, it was a quick high I was all up
You’ll get your high any time, your high the whole time It strengthens up things
High as a kite I was spinning up
I’m up real high I went down stiff of it
You are all “up”
I am up real high but if I have not got it I am down as low as you can get
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and that gave me a high feeling. And it gave me high spirits when I was down, I smoked
a cig. Or when I quarrelled with someone it made me down completely. /Hungarian data/
I don’t wanna hurt myself, but it’s gonna come that far. It’s gonna happen. I don’t wanna
die, I’m only 25, I’m too young to die. But the way it’s all coming in around me, it just
takes a lot out of ya. Some mornings I just wake up feeling so down, you just wouldn’t
care if you walked out in front of a lorry, it’d make you feel good. If a lorry came and hit
me this morning it wouldn’t bother me one bit, I wouldn’t care like. It’s just your down
and out and that’s it. /Irish data/
The metaphorical source domains of the conceptual target domain of consequences of SC
were also detected in the deterioration. The SC had also contributed to severe physical and
mental deterioration (Table 7).
And eventually, SC consequences were described as something lethal (Tables 8 and 9).
It’s killing us all bit by bit, day by day ... It’s serious stuff, I just don’t want it, don’t need
it, just don’t want it near me, don’t need it” /Irish data/
Discussion
We present here the first known attempt to analyse the conceptual metaphors (Lakoff and
Johnson 1980) in user experiences of synthetic cannabinoids (SCs) in two countries, Ireland
Table 5 Effects of SC use: losing control
Irish data Hungarian data
Taking control My brain took a turn
I wasn’t me The substance changes you
It’s taken over my life and I do not want to do it My body demanded it
Like herbal plays tricks with your mind too, It gives you bad
thoughts
It leads me, it actually leads me, leads you to
do things you would never do
Everything started spinning around me It takes the power over you and then governs
Everything just went around me I realized that I was not me anymore
If I could get it then it was got, I got it. I have often seen myself
starving and buying it
I was not conscious
But when I smoke the herbal it seems to keep that voice down a
bit, dies the voice down a bit, it seems to kill the voice
I was teased (by the substance) like I was not
controlling myself
It was reigning on me
Table 6 Consequences of SC use: change in vertical perception
Irish data Hungarian data
If you do not have it you feel down, angry You slip down to the ground
I never came off it since, I cannot get away from it, feeling so down I was all down, all deteriorated
It’s just your down and out and that’s it My whole self-regard was down
if I have not got it I’m down as low as you can get
I got very fed up
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and Hungary. Users in our study were primarily young male adults, with reviews estimating
that males appear more than twice as likely to use SCs (Castellanos et al. 2011; Forrester et al.
2011; Hu et al. 2011; Vandrey et al. 2012). We know that poly substance use is common
among users of SCs (Castellanos et al. 2011; Hu et al. 2011; Vandrey et al. 2012). The selected
narratives encompassed the motivations, the effects and the consequences which users
encountered when using SCs in two distinct countries. We recognize that these SC
narratives originate from both dependent users and users in recovery who are reflecting on
their motivations, the effects and consequences of their SC usage.
According to the identified metaphors in the study, we consider the drug usage phenom-
enon as an embodied experience, that is indescribable by rigid, theoretical categories. Wallace
(2004) argues that ‘addiction should be seen as a fluid, embodied process in which an
organism moves towards and away from homeostasis (rather than a discrete mental state,
“caused” by a drug)’ (Wallace 2004, p. 195). Thus, we demonstrate that the description of the
drug usage experience can be understood by the conceptual metaphor analysis of language use
of the drug users. Conceptual metaphor theory captures the embodied experience in language
use by analysing the conceptual source domains.
The metaphorical analysis of these user narratives revealed that users perceive the SC to be
everywhere they are and one which is especially overwhelming and all encompassing. This
concept, as a metaphorical understanding, depicts SC as a magnetic force around the user, an
inescapable trigger, always available, and one which renders the SC user powerless to decline,
reduce or cease use. Extant literature underscores how SC is an NPS primarily ‘smoked for
euphoria’ (Bebarta et al. 2012; Castellanos et al. 2011), initially regarded by users to incur
positive personal experiences (Arfken et al. 2014) and with reasons for the first time use
centring on curiosity, legality, availability and recreational effects (Barratt et al. 2013; Bonar
et al. 2014). Desired effects for SC users are underpinned by the sense of elation and altered
perception of reality (Fattore and Fratta 2011; Kjellgren and Jonsson 2013) and vary in the
onset of effect and duration of action (Schneir et al. 2011).
Our analysis revealed that the general SC body experiences are dynamic and characterized
by up-down orientation and are expressed consistently. Typical acute psychoactive effects as
reported by our users include an energizing, disinhibiting, euphoric, relaxing experience with
Table 7 Consequence of SC use: loss of control
Irish data Hungarian data
To get away from it I need to be put into a clinic It totally controlled me
I never came off it since, I cannot get away from it I wasn’t me, it was governing me
I can’t seem to get away from it
Table 8 Consequence of SC use: destruction of the body
Irish data Hungarian data
It ruins your skin It totally ruins (you)
It is damaging your health It ruins like I don’t know what
It infects your skin and
everything
It crushes you
It ruins… the… whole inner world, it ruins it, like I would be a piece of wood,
only a body
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mild perceptual alterations, increased creativity and mild memory and attentional impairments
(Spaderna et al. 2013; Van Hout and Hearne 2017). The SC as an embodied experience causes
changes in the users’ perception and this change is reflected in the language used. These can
range to the negative in altering cognitive and visual abilities, stimulating anxiety, hallucina-
tions, extreme fear and motor impairment (Müller et al. 2010; Castellanos et al. 2011; Forrester
et al. 2011; Gunderson et al. 2012). Perceptual changes on use of SCs reported in the literature
include peripheral numbness, tingling, migratory flushing or cooling and altered depth per-
ception (Schifano et al. 2009).
Metaphorical analysis across both countries revealed the inner experience of such symp-
toms. With both metaphors of SC as a magnetic field and SC as a destructive entity, users
express and describe symptoms of anxiety (and de-realisation), unusual behaviours and
thoughts, loss of reality or psychosis and fears around mental health conditions. Generally,
SCs exhibit similar side effects to high-dose natural cannabis, but are more harmful
(Hermanns-Clausen et al. 2013). Given the variability in content and potency of SC products,
duration of effect (and residual effects) can last for hours (Schneir et al. 2011; Spaderna et al.
2013), and can contribute to a range of unpleasant experiences and risk of overdose (Tuv et al.
2012; Van Hout and Hearne 2017). Serious side effects include anxiety, decreased motor
coordination, fast or irregular heartbeat, psychotic presentations and agitation (Every-Palmer
2011; Müller et al. 2010; Nacca et al. 2013; Barratt et al. 2013; Bassir Nia et al. 2016;
Baumann et al. 2014; Fattore 2016; Hurst et al. 2011; Tuv et al. 2012). Emergency presenta-
tions describing such acute intoxication report on patient panic attacks, loss of consciousness,
nausea, tachycardia, paranoid ideation, agitation, suicidal ideation, confused states and hallu-
cinations, with symptoms emerging in the hours post consumption (Vearrier and Osterhoudt
2010; Sobolevsky et al. 2010; Van Der Veer and Friday 2011; Bebarta et al. 2012). Agitated
delirium lasting for days has been observed (Berry-Cabán et al. 2013).
The conceptual metaphors of SC as a destroying entity reflect that the user becomes more
and more powerless and the SC is perceived as something that holds the power and becomes
progressively autonomous. Users described the intention to stop using, but an inherent sense of
fear and panic around psychotic episodes and self-harming when abstinent. Kassai et al.
(2017a, b) showed that SC users experience that their personality is ‘hijacked’ and they
compared SC use to a type of trauma that ‘totally destroys their soul’. Across both countries,
we found similar metaphorical concepts. This coupled with the sense that it (SC) is all around
the users, contributes to the loss of power, and the objectification of SC (MacLachlan 2004).
The protection of the self occurs whereby the user is distanced from the issue of SC and the
distress it causes to the individual because it disconnects the ‘self’ from the thing (the SC) that
is damaging him/her (MacLachlan 2004). The complexities around how to stop using SC
across both countries were confounded by these discrepancies and conflicts. Disembodiment
such as what is characterized within the SC experiences is that the body cannot organize or
Table 9 Consequence of SC use: SC is lethal
Irish data Hungarian data
It’s killing me bit by bit (?) My personality got weakened
It’s killing me bit by bit It distorted my personality completely
It’s killing us all bit by bit, day by day
it’s killing us all
It’s killing me like
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summon different feelings up and down at the same time or consecutively but very quickly
(Merleau-Ponty 2002). Dependence and loss of control are well observed in the literature on
SC abuse, and characterized by rapid tolerance development, SC craving, clear withdrawal
symptomatology and continuous urge to consume (Zimmermann et al. 2009; Vardakou et al.
2010; Fattore and Fratta 2011; Van Hout and Hearne 2017). Hence, it is intended that these
metaphors can be used to provide clinicians with an insight into the experiences of SC
motivations, effects and consequences, and better inform and guide clinical and therapeutic
responses in supporting SC recovering addicts. Limitations centre on small sample and that
samples differed by virtue of situation within the addiction recovery pathway (Shinebourne
and Smith 2010).
Conclusion
We present here a unique metaphorical insight into SC users’ experiences of motivation,
effects and consequences. It is intended that these key insights underpinned by loss of control,
fear and psychiatric illness can better inform and guide appropriate clinical and addiction
responses to support recovery. ‘Standard diagnostic assessment’ relies on the description of
symptom clusters often devoid of personal meaning and experiences, which is fundamental to
the language of recovery (Mould et al. 2010). Effective communication with former SC users
will become easier and better understood, as professionals can talk in ‘their language’ in
therapy, in prevention and in harm reduction messages. This can be especially challenging in
the case of NPS when the users themselves are not aware of what they have actually taken.
Compliance with Ethical Standards
Conflict of Interest The authors declare that they have no competing interests.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and repro-
duction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were made.
References
Arfken, C. L., Owens, D., Madeja, C., & DeAngelis, C. (2014). Exploratory comparative study on the diffusion
of synthetic cannabinoids and synthetic cathinones. Journal of Psychoactive Drugs, 46(5), 362–368.
Barnard, M., Russell, C., McKeganey, N., & Hamilton-Barclay, T. (2017). The highs and lows of NPS/“legal high” use:
qualitative views from a UK online survey. Drugs: Education, Prevention and Policy, 24(1), 96–102.
Barratt, M. J., Cakic, V., & Lenton, S. (2013). Patterns of synthetic cannabinoid use in Australia. Drug and
Alcohol Review, 32(2), 141–146.
Bassir Nia, A., Medrano, B., Perkel, C., Galynker, I., & Hurd, Y. L. (2016). Psychiatric comorbidity associated
with synthetic cannabinoid use compared to cannabis. Journal of Psychopharmacology, 30(12), 1321–1330.
Baumann, M. H., Solis, E., Watterson, L. R., Marusich, J. A., Fantegrossi, W. E., & Wiley, J. L. (2014). Baths
salts, spice, and related designer drugs: the science behind the headlines. Journal of Neuroscience, 34(46),
15150–15158.
Bebarta, V. S., Ramirez, S., & Varney, S. M. (2012). Spice: a new “legal” herbal mixture abused by young active
duty military personnel. Substance Abuse, 33(2), 191–194.
International Journal of Mental Health and Addiction
Berry-Cabán, C. S., Ee, J., Ingram, V., Berry, C. E., & Kim, E. H. (2013). Synthetic cannabinoid overdose in a
20-year-old male US soldier. Substance Abuse, 34(1), 70–72.
Bilgrei, O. R. (2016). From “herbal highs” to the “heroin of cannabis”: exploring the evolving discourse on
synthetic cannabinoid use in a Norwegian Internet drug forum. International Journal of Drug Policy, 29, 1–8.
Bonar, E. E., Ashrafioun, L., & Ilgen, M. A. (2014). Synthetic cannabinoid use among patients in residential
substance use disorder treatment: prevalence, motives, and correlates. Drug and Alcohol Dependence, 143,
268–271.
Bright, S. J., Bishop, B., Kane, R., Marsh, A., & Barratt, M. J. (2013). Kronic hysteria: exploring the intersection
between Australian synthetic cannabis legislation, the media, and drug-related harm. International Journal
of Drug Policy, 24(3), 231–237.
Castaneto, M. S., Gorelick, D. A., Desrosiers, N. A., Hartman, R. L., Pirard, S., & Huestis, M. A. (2014).
Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug and Alcohol
Dependence, 144, 12–41.
Castellanos, D., Singh, S., Thornton, G., Avila, M., & Moreno, A. (2011). Synthetic cannabinoid use: a case
series of adolescents. Journal of Adolescent Health, 49(4), 347–349.
Corazza, O., Assi, S., Simonato, P., Corkery, J., Bersani, F. S., Demetrovics, Z., et al. (2013). Promoting
innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: the
outcomes of the ReDNet project.Human Psychopharmacology: Clinical and Experimental, 28(4), 317–323.
Dolengevich-Segal, H., Rodríguez-Salgado, B., Gómez-Arnau, J., & Sánchez-Mateos, D. (2017). An approach to
the new psychoactive drugs phenomenon. Salud Mental, 40(2), 71–82.
Dresen, S., Kneisel, S., Weinmann, W., Zimmermann, R., & Auwärter, V. (2011). Development and validation of
a liquid chromatography–tandem mass spectrometry method for the quantitation of synthetic cannabinoids
of the aminoalkylindole type and methanandamide in serum and its application to forensic samples. Journal
of Mass Spectrometry, 46(2), 163–171.
EMCDDA. (2015). New psychoactive substances in Europe. An update from the EU Early Warning System,
http://www.emcdda.europa.eu/system/files/publications/65/TD0415135ENN.pdf. Accessed 05 July 2016.
Ernst, L., Schiebel, H. M., Theuring, C., Lindigkeit, R., & Beuerle, T. (2011). Identification and characterization
of JWH-122 used as new ingredient in “spice-like” herbal incenses. Forensic Science International, 208(1–
3), e31–e35.
European Monitoring Centre for Drugs and Drug Addiction – EMCDDA. (2009). Thematic paper—understand-
ing the ‘spice’ phenomenon. Office for Official Publications of the European Communities, Luxembourg.
Available via DIALOG. http://www.emcdda.europa.eu/attachements.cfm/att_80086_EN_EMCDDA_
Understanding%20the%20‘Spice’%20phenomenon_4Update%2020090813.pdf. Accessed 30 May 2017.
Every-Palmer, S. (2010). Warning: legal synthetic cannabinoid-receptor agonists such as JWH-018 may precip-
itate psychosis in vulnerable individuals. Addiction, 105(10), 1859–1860.
Every-Palmer, S. (2011). Synthetic cannabinoid JWH-018 and psychosis: an explorative study.Drug and Alcohol
Dependence, 117(2–3), 152–157.
Fantegrossi, W. E., Moran, J. H., Radominska-Pandya, A., & Prather, P. L. (2014). Distinct pharmacology and
metabolism of K2 synthetic cannabinoids compared to Δ9-THC: mechanism underlying greater toxicity?
Life Sciences, 97(1), 45–54.
Fattore, L. (2016). Synthetic cannabinoids—further evidence supporting the relationship between cannabinoids
and psychosis. Biological Psychiatry, 79(7), 539–548.
Fattore, L., & Fratta, W. (2011). Beyond THC: the new generation of cannabinoid designer drugs. Frontiers in
Behavioral Neuroscience, 5, 60.
Forrester, M. B., Kleinschmidt, K., Schwarz, E., & Young, A. (2011). Synthetic cannabinoid exposures reported
to Texas poison centers. Journal of Addictive Diseases, 30(4), 351–358.
Gerçek, C. (2017). The evaluation of students’ mental images of cigarette through metaphor analysis. Eurasia
Journal of Mathematics, Science & Technology Education, 13(1), 105–111.
Gibbs Jr., R. W. (2006). Metaphor interpretation as embodied simulation. Mind & Language, 21(3), 434–458.
Griffiths, P., Sedefov, R., Gallegos, A. N. A., & Lopez, D. (2010). How globalization and market innovation
challenge how we think about and respond to drug use:‘Spice’ a case study. Addiction, 105(6), 951–953.
Gryczynski, J., Johnson, J., & Coyhis, D. (2007). The healing forest metaphor revisited: the seen and “unseen
world” of drug use. Substance Use & Misuse, 42(2–3), 475–484.
Gunderson, E. W., Haughey, H. M., Ait-Daoud, N., Joshi, A. S., & Hart, C. L. (2012). “Spice” and “K2” herbal
highs: a case series and systematic review of the clinical effects and biopsychosocial implications of
synthetic cannabinoid use in humans. The American Journal on Addictions, 21(4), 320–326.
Hermanns-Clausen, M., Kneisel, S., Szabo, B., & Auwärter, V. (2013). Acute toxicity due to the confirmed
consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction, 108(3), 534–544.
Hu, X., Primack, B. A., Barnett, T. E., & Cook, R. L. (2011). College students and use of K2: an emerging drug
of abuse in young persons. Substance Abuse Treatment, Prevention, and Policy, 6(1), 16.
International Journal of Mental Health and Addiction
Hudson, S., Ramsey, J., King, L., Timbers, S., Maynard, S., Dargan, P. I., & Wood, D. M. (2010). Use of high-
resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in
“herbal high” products. Journal of Analytical Toxicology, 34(5), 252–260.
Hurst, D., Loeffler, G., & McLay, R. (2011). Psychosis associated with synthetic cannabinoid agonists: a case
series. American Journal of Psychiatry, 168(10), 1119–1119.
Jellinek, E. M. (1946). Phases in the drinking history of alcoholics. Analysis of a survey conducted by the official
organ of alcoholics anonymous (memoirs of the section of studies on alcohol). Quarterly Journal of Studies
on Alcohol, 7(1), 1–88.
Johnson, M., & Lakoff, G. (2002). Why cognitive linguistics requires embodied realism. Cognitive Linguistics,
13(3), 245–264.
Kaló, Z. S., Vida, K., Gogibedasvili, A., Van Hout, M. C., & Rácz, J. (2013). English-Hungarian comparative
study on metaphors of intravenous mephedrone use. European Society for Social Drug Research Annual
Conference, Stockholm.
Kassai, S., Pintér, J. N., Rácz, J., Böröndi, B., Tóth-Karikó, T., Kerekes, K., & Gyarmathy, V. A. (2017a).
Assessing the experience of using synthetic cannabinoids by means of interpretative phenomenological
analysis. Harm Reduction Journal, 14(1), 9.
Kassai, S., Pintér, J. N., Rácz, J., Erdősi, D., Milibák, R., & Gyarmathy, V. A. (2017b). Using interpretative
phenomenological analysis to assess identity formation among users of synthetic cannabinoids. International
Journal of Mental Health and Addiction, 15(5), 1047–1054.
Kjellgren, A., & Jonsson, K. (2013). Methoxetamine (MXE) – A phenomenological study of experiences
induced by a “Legal High” from the internet. Journal of Psychoactive Drugs, 45(3), 276–286. https://doi.
org/10.1080/02791072.2013.803647.
Kikura-Hanajiri, R., Uchiyama, N., & Goda, Y. (2011). Survey of current trends in the abuse of psychotropic
substances and plants in Japan. Legal Medicine, 13(3), 109–115.
Kövecses, Z. (2003). Metaphor and emotion: language, culture, and body in human feeling. Cambridge:
Cambridge University Press.
Kovecses, Z. (2010). Metaphor: a practical introduction. New York: Oxford University Press.
Lakoff, G., & Johnson, M. (1980). Metaphors we live by. University of Chicago press.
Lindigkeit, R., Boehme, A., Eiserloh, I., Luebbecke, M., Wiggermann, M., Ernst, L., & Beuerle, T. (2009). Spice:
a never ending story? Forensic Science International, 191(1–3), 58–63.
Macfarlane, V., & Christie, G. (2015). Synthetic cannabinoid withdrawal: a new demand on detoxification
services. Drug and Alcohol Review, 34(2), 147–153.
MacLachlan, M. (2004). Disembodied language. In M. MacLachlan (Ed.), Embodiment. Clinical, critical and
cultural perspectives on health and illness (26-27). Open University Press.
Merleau-Ponty, M. (2002). Phenomenology of perception. London: Routledge.
Meshack, A., Peters Jr., R. J., Lin, M. T., Hill, M., Abughosh, S., Essien, E. J., & Savage, C. (2013). The beliefs
of teenage male cannabinoid users: a qualitative study. American Journal of Health Studies, 28(3).
Michie, S., Van Stralen, M. M., &West, R. (2011). The behaviour change wheel: a new method for characterising
and designing behaviour change interventions. Implementation Science, 6(1), 42.
Moore, D., Fraser, S., Törrönen, J., & Tinghög, M. E. (2015). Sameness and difference: metaphor and politics in
the constitution of addiction, social exclusion and gender in Australian and Swedish drug policy.
International Journal of Drug Policy, 26(4), 420–428.
Moser, K. S. (2000). Metaphor analysis in psychology—method, theory, and fields of application. In Forum
Qualitative Sozialforschung/Forum: Qualitative Social Research (Vol. 1, no. 2).
Mould, T. J., Oades, L. G., & Crowe, T. P. (2010). The use of metaphor for understanding and managing
psychotic experiences: a systematic review. Journal of Mental Health, 19(3), 282–293.
Müller, H., Sperling, W., Köhrmann, M., Huttner, H. B., Kornhuber, J., & Maler, J. M. (2010). The synthetic
cannabinoid spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes.
Schizophrenia Research, 118(1), 309–310.
Nacca, N., Vatti, D., Sullivan, R., Sud, P., Su, M., & Marraffa, J. (2013). The synthetic cannabinoid withdrawal
syndrome. Journal of Addiction Medicine, 7(4), 296–298.
Perlman, D. C., & Jordan, A. E. (2017). To neither target, capture, surveille, nor wage war: on-going need for
attention to metaphor theory in care and prevention for people who use drugs. Journal of Addictive Diseases,
36(1), 1–4.
Rácz J., & Kaló, Z. S. (2009). Metaforák és pszichoaktív anyaghasználat. [Metaphors and psychoactive
substance use] Korunk, Retrived from: http://www.korunk.org/?q=node/8&ev=2009&honap=7
&cikk=10870. Access date: 2017–07-09.
Rácz, J., Csák, R., Tóth, K. T., Tóth, E., Rozmán, K., & Gyarmathy, V. A. (2016). Veni, vidi, vici: the appearance
and dominance of new psychoactive substances among new participants at the largest needle exchange
program in Hungary between 2006 and 2014. Drug and Alcohol Dependence, 158, 154–158.
International Journal of Mental Health and Addiction
Reitox National Focal Point. (2016). National Report to the EMCDDA, R.N.F. Point, 2016.
http://drogfokuszpont.hu/wp-content/uploads/HU_National_Report_2016.pdf. Accessed 18 Jan 2017.
Roussel, O., Carlin, M. G., Bouvot, X., & Tensorer, L. (2015). The emergence of synthetic cannabinoids in
Mayotte. Toxicologie Analytique et Clinique, 27(1), 18–22.
Schifano, F., Corazza, O., Deluca, P., Davey, Z., Di Furia, L., Farre’, M., et al. (2009). Psychoactive drug or
mystical incense? Overview of the online available information on spice products. International Journal of
Culture and Mental Health, 2(2), 137–144.
Schmitt, R. (2005). Systematic metaphor analysis as a method of qualitative research. The Qualitative Report,
10(2), 358–394.
Schneir, A. B., Cullen, J., & Ly, B. T. (2011). “Spice” girls: synthetic cannabinoid intoxication. The Journal of
Emergency Medicine, 40(3), 296–299.
Shinebourne, P., & Smith, J. A. (2010). The communicative power of metaphors: an analysis and interpretation of
metaphors in accounts of the experience of addiction. Psychology and Psychotherapy: Theory, Research and
Practice, 83(1), 59–73.
Sobolevsky, T., Prasolov, I., & Rodchenkov, G. (2010). Detection of JWH-018 metabolites in smoking mixture
post-administration urine. Forensic Science International, 200(1–3), 141–147.
Soussan, C., & Kjellgren, A. (2014). The flip side of “spice”: the adverse effects of synthetic cannabinoids as
discussed on a Swedish internet forum. Nordic Studies on Alcohol and Drugs, 31(2), 207–220.
Spaderna, M., Addy, P. H., & D’Souza, D. C. (2013). Spicing things up: synthetic cannabinoids.
Psychopharmacology, 228(4), 525–540.
Tait, R. J., Caldicott, D., Mountain, D., Hill, S. L., & Lenton, S. (2016). A systematic review of adverse events arising
from the use of synthetic cannabinoids and their associated treatment. Clinical Toxicology, 54(1), 1–13.
Tung, C. K., Chiang, T. P., & Lam, M. (2012). Acute mental disturbance caused by synthetic cannabinoid: a
potential emerging substance of abuse in Hong Kong. East Asian Archives of Psychiatry, 22(1), 31–33.
Tuv, S. S., Strand, M. C., Karinen, R., Øiestad, E. L., Christophersen, A. S., & Vindenes, V. (2012). Effect and
occurrence of synthetic cannabinoids. Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin,
ny raekke, 132(20), 2285–2288.
Uchiyama, N., Kikura-Hanajiri, R., Ogata, J., & Goda, Y. (2010). Chemical analysis of synthetic cannabinoids as
designer drugs in herbal products. Forensic Science International, 198(1–3), 31–38.
UNODC. (2013). The challenge of new psychoactive substances. A Report from the Global SMART Program.
Available at: https://www.unodc.org/documents/scientific/NPS_2013_SMART.pdf. Retrived: 22-04-2018.
Van Der Veer, N., & Friday, J. (2011). Persistent psychosis following the use of spice. Schizophrenia Research,
130(1), 285–286.
Van Hout, M. C. (2017). The dynamic landscape of novel psychoactive substance (NPS) use in Ireland: results
from an expert consultation. International Journal of Mental Health and Addiction, 15(5), 985–992.
Van Hout, M. C., & Bingham, T. (2012). “A costly turn on”: patterns of use and perceived consequences of
mephedrone based head shop products amongst Irish injectors. International Journal of Drug Policy, 23(3),
188–197.
Van Hout, M. C., & Brennan, R. (2011a). Plant food for thought: a qualitative study of mephedrone use in
Ireland. Drugs: Education, Prevention and Policy, 18(5), 371–381.
Van Hout, M. C., & Brennan, R. (2011b). “Bump and grind”: an exploratory study of mephedrone users’
perceptions of sexuality and sexual risk. Drugs and Alcohol Today, 11(2), 93–103.
Van Hout, M. C., & Brennan, R. (2011c). ‘Heads held high’: an exploratory study of legal highs in pre-legislation
Ireland. Journal of Ethnicity in Substance Abuse, 10(3), 256–272.
Van Hout, M. C., & Brennan, R. (2012). Curiosity killed M-cat: a post-legislative study on mephedrone use in
Ireland. Drugs: Education, Prevention and Policy, 19(2), 156–162.
Van Hout, M. C., & Hearne, E. (2017). User experiences of development of dependence on the synthetic
cannabinoids, 5f-AKB48 and 5F-PB-22, and subsequent withdrawal syndromes. International Journal of
Mental Health and Addiction, 15(3), 565–579.
Vandrey, R., Dunn, K. E., Fry, J. A., & Girling, E. R. (2012). A survey study to characterize use of spice products
(synthetic cannabinoids). Drug and Alcohol Dependence, 120(1–3), 238–241.
Vardakou, I., Pistos, C., & Spiliopoulou, C. (2010). Spice drugs as a new trend: Mode of action, identification
and legislation. Toxicology Letters, 197(3), 157–162.
Vearrier, D., & Osterhoudt, K. C. (2010). A teenager with agitation: higher than she should have climbed.
Pediatric Emergency Care, 26(6), 462–465.
Wallace, B. (2004). Editorial. Addiction Research and Theory, 12(3), 195–199.
Westphal, F., Junge, T., Sönnichsen, F., Rösner, P., & Schäper, J. (2010). Ein neuer Wirkstoff in SPICE-artigen
Kräutermischungen: Charakterisierung von JWH-250, seinen methyl-und Trimethylsilylderivaten. [a new
compound in herbal mixtures: characterisation of JWH-250, its methyl- and trimethylsilyl-derivatives].
Toxichem Krimtech, 77(1), 8–22.
International Journal of Mental Health and Addiction
Winstock, A. R., & Barratt, M. J. (2013). Synthetic cannabis: a comparison of patterns of use and effect profile
with natural cannabis in a large global sample. Drug and Alcohol Dependence, 131(1–2), 106–111.
Winstock, A., Lynskey, M., Borschmann, R., & Waldron, J. (2015). Risk of emergency medical treatment
following consumption of cannabis or synthetic cannabinoids in a large global sample. Journal of
Psychopharmacology, 29(6), 698–703.
Zawilska, J. B., & Wojcieszak, J. (2014). Spice/K2 drugs—more than innocent substitutes for marijuana.
International Journal of Neuropsychopharmacology, 17(3), 509–525.
Zimmermann, U. S., Winkelmann, P. R., Pilhatsch, M., Nees, J. A., Spanagel, R., & Schulz, K. (2009).
Withdrawal phenomena and dependence syndrome after the consumption of “spice gold”. Deutsches
Ärzteblatt International, 106(27), 464–467.
Zuba, D., Byrska, B., & Maciow, M. (2011). Comparison of “herbal highs” composition. Analytical and
Bioanalytical Chemistry, 400(1), 119–126.
Affiliations
Zsuzsa Kaló1 & Szilvia Kassai1,2 & József Rácz1,3 & Marie Claire Van Hout4
* Marie Claire Van Hout
m.c.vanhout@ljmu.ac.uk
1 Institute of Psychology, ELTE Eötvös Loránd University, Izabella street 46, Budapest 1064, Hungary
2 Doctoral School of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary
3 Faculty of Health Sciences, Semmelweis University, Vas street 17, Budapest 1088, Hungary
4 Public Health Institute, Liverpool JohnMoore’s University, United Kingdom Henry Cotton Campus Level 2
15-21 Webster Street, Liverpool L3 2ET, UK
International Journal of Mental Health and Addiction
